Articles

In 2010, more than 10 million people in Burkina Faso lined up to receive the first licensed doses of MenAfriVac® and changed the course of meningitis in sub-Saharan Africa.

For most communities in high-resource countries, typhoid fever feels like a distant memory. But for people living in low- and middle-income countries, typhoid is still a present danger.

PATH and the eight visionary tech companies in the Visualize No Malaria initiative pledge to stand with frontline health workers and the people of Zambia to eliminate malaria.

A suite of five cloud-based software solutions, jointly developed by PATH and FERCI, aims to improve, strengthen, and build the capacity of clinical researchers in India and beyond.